Literature DB >> 10592654

Hepatitis C epidemiology.

D L Thomas1.   

Abstract

Hepatitis C virus infection occurs in all parts of the world. Infection is generally due to percutaneous exposures, though sexual and perinatal transmission may occur. While further study is needed to elucidate the biology of HCV transmission and develop vaccines for prevention, new HCV infections can be reduced by economic development and education regarding blood-borne infections.

Entities:  

Mesh：

Year:  2000        PMID： 10592654     DOI： 10.1007/978-3-642-59605-6_2

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


  11 in total

1.  Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection.

Authors:  J Encke; J Findeklee; J Geib; E Pfaff; W Stremmel
Journal:  Clin Exp Immunol       Date:  2005-11       Impact factor: 4.330

2.  Ultra-structural localisation of hepatocellular PKR protein using immuno-gold labelling in chronic hepatitis C virus disease.

Authors:  Gerry C MacQuillan; Paul Caterina; Bastiaan de Boer; Jane E Allan; Michael A Platten; William D Reed; Gary P Jeffrey
Journal:  J Mol Histol       Date:  2009-07-30       Impact factor: 2.611

3.  Necessity for reassessment of patients with serogroup 2 hepatitis C virus (HCV) and undetectable serum HCV RNA.

Authors:  Yuki Moritou; Fusao Ikeda; Yasuto Takeuchi; Hiroyuki Seki; Shintaro Nanba; Yoshiaki Iwasaki; Kazuhide Yamamoto
Journal:  J Clin Microbiol       Date:  2013-12-04       Impact factor: 5.948

4.  Response of hepatitis C virus to long-term passage in the presence of alpha interferon: multiple mutations and a common phenotype.

Authors:  Celia Perales; Nathan M Beach; Isabel Gallego; Maria Eugenia Soria; Josep Quer; Juan Ignacio Esteban; Charles Rice; Esteban Domingo; Julie Sheldon
Journal:  J Virol       Date:  2013-05-01       Impact factor: 5.103

5.  Development of NS3/4A protease-based reporter assay suitable for efficiently assessing hepatitis C virus infection.

Authors:  Kao-Lu Pan; Jin-Ching Lee; Hsing-Wen Sung; Teng-Yuang Chang; John T-A Hsu
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

6.  Impaired renal allograft, but not patient survival, in patients with antibodies to hepatitis C virus.

Authors:  L Giblin; M R Clarkson; P J Conlon; J J Walshe; P O'Kelly; D Hickey; D Little; M Keoghan; J Donohoe
Journal:  Ir J Med Sci       Date:  2004 Apr-Jun       Impact factor: 1.568

7.  New preclinical antimalarial drugs potently inhibit hepatitis C virus genotype 1b RNA replication.

Authors:  Youki Ueda; Midori Takeda; Kyoko Mori; Hiromichi Dansako; Takaji Wakita; Hye-Sook Kim; Akira Sato; Yusuke Wataya; Masanori Ikeda; Nobuyuki Kato
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

8.  The DNA damage sensors ataxia-telangiectasia mutated kinase and checkpoint kinase 2 are required for hepatitis C virus RNA replication.

Authors:  Yasuo Ariumi; Misao Kuroki; Hiromichi Dansako; Ken-Ichi Abe; Masanori Ikeda; Takaji Wakita; Nobuyuki Kato
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

9.  Genetic characterization of hepatitis C virus in long-term RNA replication using Li23 cell culture systems.

Authors:  Nobuyuki Kato; Hiroe Sejima; Youki Ueda; Kyoko Mori; Shinya Satoh; Hiromichi Dansako; Masanori Ikeda
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

10.  Sexual Transmission of Hepatitis C Virus Between HIV Infected Subjects and Their Main Heterosexual Partners.

Authors:  Abbas Alipour; Abbas Rezaianzadeh; Jafar Hasanzadeh; Abdorreza Rajaeefard; Mohammad Ali Davarpanah
Journal:  Hepat Mon       Date:  2013-11-05       Impact factor: 0.660
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.